Search Results 401-410 of 11725 for Linaclotide

1. A Study Of The Drugs Selumetinib Versus Carboplatin/Vincristine In Patients With Neurofibromatosis And Low-Grade Glioma - Mayo Clinic

   Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...

2. A Study Comparing 177Lu-DOTA0-Tyr3-Octreotate To Octreotide LAR To Treat Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours - Mayo Clinic

   A Study Comparing 177Lu-DOTA0-Tyr3-Octreotate To Octreotide LAR To Treat Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid ...

3. Publications - Lauren K. Licatino, M.D. - Mayo Clinic

   Margolis R, Licatino L, Adams HD, Higgins KE 3rd, Janosy NR, Patel S, Dalton A, Oloso BA, Staffa SJ, Afonso A, Vinson AE. Contemporary Survey of the Impact ...

4. Niclosamide (oral route) - Side effects & dosage - Mayo Clinic

   Anthelmintics are medicines used in the treatment of worm infections. Niclosamide is used to treat broad or fish tapeworm, dwarf tapeworm, and beef tapeworm ...

5. Hematology - Clinical trials

   The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.

6. A Phase 2b, Study Of Linsitinib In Subjects With Active, Moderate To Severe Thyroid Eye Disease (TED) - Mayo Clinic

   The purpose of this study is to evaluate the safety and tolerability of linsitinib. Study drug is administered twice daily for six-months (24 weeks) in ...

7. Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients with Refractory or Relapsed Indolent Non-Hodgkin Lymphoma - Mayo Clinic

   RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and help kill them or carry cancer- ...

8. Gastroenterology and Hepatology - Clinical trials

   Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public health issue in the US. It is ...

9. Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

   Patients with previously untreated low tumor burden indolent Non-Hodgkin's Lymphoma (NHL) will receive either rituximab or GA101 weekly for 4 weeks followed by ...

10. Loxapine (inhalation route) - Side effects & uses - Mayo Clinic

    Inhaled loxapine is used to treat acute agitation in adult patients with schizophrenia or bipolar I disorder (type of depression). It works in the brain to ...